CIBC Bancorp USA
EW icon

CIBC Bancorp USA’s Edwards Lifesciences EW Stock Holding History

CIBC Bancorp USA’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.2M Sell
152,371
-35,543
-19% -$3.16M 0.02% 496
2026
Q2 		$17M Sell
187,914
-37,436
-17% -$3.14M 0.02% 443
2026
Q1 		$18M Buy
+225,350
New +$18.6M 0.02% 389
2025
Q3 		$6.3M Buy
+80,982
New +$6.33M 0.03% 356

Other funds holding EW

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

CIBC Bancorp USA's EW Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Edwards Lifesciences (EW) stake by 19% in Q3 2026, selling an estimated $3.16M and leaving 152,371 shares worth $13.2M. The position accounts for 0.02% of the portfolio, ranked #496.

CIBC Bancorp USA first reported a position in EW in Q3 2025 and has held it in 4 quarters since. The position peaked at $18M in Q1 2026. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • CIBC Bancorp USA held 152,371 shares of Edwards Lifesciences worth $13.2M as of Q3 2026.
  • CIBC Bancorp USA sold 35,543 Edwards Lifesciences shares in Q3 2026, an estimated $3.16M.
  • Edwards Lifesciences made up 0.02% of CIBC Bancorp USA's portfolio in Q3 2026, its #496 holding.
  • CIBC Bancorp USA first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Edwards Lifesciences position peaked at $18M in Q1 2026.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.